Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Symbio Pharmaceuticals (4582 JP)
Watchlist
34
Analysis
Health Care
•
Japan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
21 Jun 2021 17:43
Asia Shorts: Geely, Ganfeng, Pharmaron, Evergrande, Fujitsu, Canon, Renesas, Toshiba, LGD, Doosan
The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
204 Views
Share
bearish
•
Thematic (Sector/Industry)
•
16 Jun 2020 06:33
🇯🇵 JAPAN - Stress Tests Part 2 - Operating Cash Flow & Accruals
STRESS TESTS - This Insight is the second in our Japan Stress Test series in which we endeavour to assess where business risk is concentrated...
Campbell Gunn
Follow
337 Views
Share
bullish
•
Thematic (Sector/Industry)
•
28 Dec 2018 17:53
Japan Pharma - Top Picks (28 Dec 2018)
...
Dion Stéfan Büchner M.D., FCAP
902 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Dec 2018 14:43
Japan Pharma - Top Picks
While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP) is a contrarian call in anticipation of value...
Dion Stéfan Büchner M.D., FCAP
556 Views
Share
bullish
•
Quantitative Analysis
•
21 Oct 2018 20:07
Japan Fortnightly Update: Spiked
SHORT-LIVED - The much-lauded 'breakout' in the Nikkei 225 (NKY INDEX) at the end of last month proved to be short-lived. As measured by Total...
Campbell Gunn
Follow
359 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x